Tiew Pei Yee, Tay Tunn Ren, Chen Wenjia, Price David B, Ong Kheng Yong, Chotirmall Sanjay H, Koh Mariko Siyue
Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
J Allergy Clin Immunol Glob. 2023 Nov 20;3(1):100188. doi: 10.1016/j.jacig.2023.100188. eCollection 2024 Feb.
Longitudinal predictors of persistent poor asthma control in severe asthma (SA) cohort remain scarce. The predictive value of the asthma severity scoring system (ASSESS) in the SA cohort outside the original study and in the Asian population is unknown.
We sought to determine the 5-year longitudinal outcome of patients with SA and validate the use of ASSESS score in predicting future outcomes in SA.
A prospective longitudinal observational study of patients with SA attending the multidisciplinary specialist SA clinic of the Singapore General Hospital from 2011 to 2021 was conducted. The number of exacerbations and asthma control test results were recorded yearly for 5 consecutive years. The ASSESS score was computed at baseline, and the area under the receiver-operating characteristic curve for predicting persistent poor asthma control was generated.
Of the 489 patients recruited into the study, 306 patients with 5-year follow-up data were analyzed. Seventy-three percent had type 2 inflammation with increased overall exacerbations over 5 years (rate ratio, 2.55; 95% CI, 1.31-4.96; = .006) relative to non-type 2 SA. In the multivariate model, bronchiectasis, gastroesophageal reflux disease, and an asthma control test score of less than 20 were significantly associated with persistent poor asthma control over 5 years. ASSESS scores were good at predicting persistent poor asthma control with an area under the receiver-operating characteristic curve of 0.71 (95% CI, 0.57-0.84).
Bronchiectasis and gastroesophageal reflux disease are predictors for persistent poor asthma control and targeted traits for precision medicine in SA. The ASSESS score has a good prediction for persistent poor asthma control over 5 years.
严重哮喘(SA)队列中持续性哮喘控制不佳的纵向预测因素仍然很少。哮喘严重程度评分系统(ASSESS)在原研究之外的SA队列以及亚洲人群中的预测价值尚不清楚。
我们试图确定SA患者的5年纵向结局,并验证ASSESS评分在预测SA未来结局中的应用。
对2011年至2021年在新加坡总医院多学科专科SA诊所就诊的SA患者进行了一项前瞻性纵向观察研究。连续5年每年记录发作次数和哮喘控制测试结果。在基线时计算ASSESS评分,并生成预测持续性哮喘控制不佳的受试者工作特征曲线下面积。
在纳入研究的489例患者中,对306例有5年随访数据的患者进行了分析。相对于非2型SA,73%的患者有2型炎症,5年期间总体发作增加(率比,2.55;95%CI,1.31-4.96;P = .006)。在多变量模型中,支气管扩张、胃食管反流病以及哮喘控制测试评分低于20与5年期间持续性哮喘控制不佳显著相关。ASSESS评分在预测持续性哮喘控制不佳方面表现良好,受试者工作特征曲线下面积为0.71(95%CI,0.57-0.84)。
支气管扩张和胃食管反流病是SA中持续性哮喘控制不佳的预测因素,也是精准医学的靶向特征。ASSESS评分对5年期间持续性哮喘控制不佳有良好的预测作用。